NEW YORK, April 3, 2015 /PRNewswire/ --
Auspex Pharmaceuticals, Inc.
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Auspex Pharmaceuticals, Inc. ("ASPX") to Teva Pharmaceutical Industries Ltd. in a...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]therapeutics-inc-and-norcraf-3